More recently, it was assessed that metformin, a commonly prescribed anti-hyperglycemic agent used in the treatment of T2DM, was also able to counteract ROS production and protein carbonylation through the upregulation of chaperone proteins, such as Hsp60, Hsp70, and LonP1 [69]. Here, HSPD1 is linked to type 2 diabetes mellitus.